Table of contents
- Coronavirus (COVID-19)
- Coronavirus (COVID-19): Pay no import duty and VAT on medical supplies, equipment and protective garments
- Coronavirus (COVID-19)—MHRA on-site Good Practice inspections to resume
- Amending Decision on relief from import duties and VAT exemption on importation granted for goods to combat coronavirus (COVID-19) published in Official Journal
- Coronavirus (COVID-19)—Government invests over £100m to manufacture vaccines
- Commons opens inquiry into role of technology in UK’s recovery from coronavirus (COVID-19)
- Coronavirus (COVID-19)—UK’s decision to reject EU vaccine scheme challenged
- Additional doses of coronavirus (COVID-19) vaccine secured by government
- EMA reviews the use of dexamethasone to treat coronavirus (COVID-19)
- Coronavirus (COVID-19)—Lloyd’s to insure transport of vaccine to emerging economies
More sections of this document available when you sign-in to Lexis+ or register for a free trial.
Article summary
This week's edition of Life Sciences weekly highlights includes the latest Brexit and coronavirus (COVID-19) developments, the publication of a working draft of the proposed 2021 Pharmaceutical Code of Practice currently under consultation and an updated draft of comprehensive Q&A guidance relating to Regulation (EU) 536/2014 (the Clinical Trials Regulation) and the launch by Innovation Medicines Initiative (IMI) of its blockchain project PharmaLedger.
To continue reading this news article, as well as thousands of others like it, sign in with LexisNexis or register for a free trial